Table 1.
Patient Characteristics
| Patient Group | |||
|---|---|---|---|
| cART(n=10) | untreated (n=10) | control (n=10)* | |
| Age (range, mean) | 37–58, 50.4 | 35–53, 44.3 | 24–52, 36 |
| CD4+ T cells in cells/ml (range, mean) | 228–953, 621.2 | 160–810, 342.1 | N/A |
| Viral load in copies/ml (range, mean) | <50 | 2220–202,000, 44,202.2 | N/A |
| Sex (#) | |||
| male | 8 | 9 | 7 |
| female | 2 | 1 | 2 |
| unknown | 0 | 0 | 1 |
| Race (#) | |||
| white | 0 | 2 | 2 |
| hispanic | 4 | 2 | 3 |
| black | 5 | 4 | 0 |
| other or unknown | 1 | 1 | 5 |
*
Data listed for controls represents plasma samples used for cytokine secretion assays presented in Figure 1A+B. Due to specimen availability, additional control donor plasma was substituted in certain experiments